NEW DELHI – U.S. drugmaker Amgen plans to invest approximately $200 million this year in its new technology center located in southern India, with additional investments anticipated, CEO Robert ...
Amgen Inc. (NASDAQ:AMGN) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ETCompany ParticipantsJay Bradner - Executive ...
Rascal Flatts heads home to Columbus, where music is in full swing this weekend. Plus, a "Hamlet"-inspired play and two art exhibitions open.
Amgen (NASDAQ: AMGN) will present at the 45th Annual TD Cowen Health Care Conference at 9:10 a.m. ET on Wednesday, March 5, 2025. Jay Bradner, executive vice president of Research and Development at ...
Intel Corp. is slowing down construction of its Ohio complex again, with the semiconductor maker now saying the fabs will ...
US drug major Amgen on Monday announced the opening of its new technology and innovation site in Hyderabad. The company said it plans to invest $200 million through 2025, with additional ...
Amgen will invest $200 million in its new technology centre in Hyderabad, India, this year, with plans for further investments. The centre, focused on AI and data science for drug development, will ...
Som Chattopadhyay, national executive India, Amgen, said the first 300 employees were hired within 78 days of signing the contract for the new facility and another 300 are to be onboarded soon ...
HYDERABAD, India (Reuters) - U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, CEO Robert Bradway said ...
Reuters is an international news organisation owned by Thomson Reuters US drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...
In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase “defensive” as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results